Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)-Reference-Cited by-同舟云学术

Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)

Published:2021-12 Issue: Volume: Page:
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

O'Connell Rachel L.,Sharma Bhupinder,Van Kerckhoven Liza,Mehdi Aia S.,Marshall Chris,Wotherspoon Andrew,Iyengar Sunil^ORCID,El-Sharkawi Dima^ORCID,Attygalle Ayoma D.,Jurgensen-Rauch Amanda^ORCID,Cunningham David^ORCID,MacNeill Fiona,Khan Aadil A.^ORCID,Tasoulis Marios-Konstantinos^ORCID

Funder

NIHR Imperial Biomedical Research Centre

National Institute for Health Research

National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference23 articles.

1. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant;Keech;Plast Reconstr Surg,1997

2. WHO classification of tumours of haematopoietic and lymphoid TissuesWHO classification of tumours;Swerdlow,2017

3. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients;Miranda;J Clin Oncol,2014

4. Breast implant–associated anaplastic large cell lymphoma: review and multiparametric imaging paradigms;Sharma;Radiographics,2020

5. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG)